Ligand Pharmaceuticals (LGND) Capital Leases (2010 - 2015)

Ligand Pharmaceuticals (LGND) has 6 years of Capital Leases data on file, last reported at $228000.0 in Q2 2015.

• For the quarter ending Q2 2015, Capital Leases fell 85.63% year-over-year to $228000.0; the trailing twelve-month figure through Jun 2015 stood at $228000.0 (down 85.63% YoY), and the FY2014 full-year result was $934000.0, down 69.59% from the prior year.
• Capital Leases retreated to $228000.0 in Q2 2015, from $577000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $9.9 million in Q2 2011 to a low of $228000.0 in Q2 2015.
• A 5-year average of $4.4 million and a median of $4.0 million in 2013 frame the typical range for Capital Leases.
• Across the five-year window, Capital Leases slipped 24.74% in 2011 and tumbled 85.63% in 2015, its largest moves.
• Tracing LGND's Capital Leases over 5 years: stood at $8.4 million in 2011, then fell by 28.73% to $6.0 million in 2012, then sank by 48.5% to $3.1 million in 2013, then tumbled by 69.59% to $934000.0 in 2014, then sank by 75.59% to $228000.0 in 2015.
• Business Quant data shows LGND's Capital Leases at $228000.0 in Q2 2015, $577000.0 in Q1 2015, and $934000.0 in Q4 2014.